Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Anemia;Kidney Failure, Chronic;Cancer, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 22, Status: Authorised

Q&A: Good clinical practice (GCP)

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 25/06/2020, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Anovulation, Date of authorisation: 27/09/2013, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Azilect, rasagiline, Parkinson Disease, Date of authorisation: 21/02/2005, Revision: 23, Status: Authorised

Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages

Member states contact points for review of national versions of the content of mobile scanning and other technologies

Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products

CTIS newsflash – 18 August 2023

10 years of the Healthcare Professionals' Working Party